Enhanced Melan-A Red Chromogen Labeling in Melanoma Compared to Nevus Cells
A Diagnostic Aid in Dual Multiplex Immunohistochemistry With Ki67.
Kundert PN, Ibrahim EH, Prieto VG, Aung PP
Journal of Cutaneous PathologyIn the feed 30 Jul 2026, published online 30 Jul 2026, issue 2026 Jul 30, added to PubMed 30 Jul 2026
Topics: Skin cancer & tumorsMelanoma & molesDermatopathology
Abstract
BACKGROUNDDistinguishing melanoma cells from nevus cells remains a diagnostic challenge, particularly in cases where melanoma exhibits nevoid morphology or nevus cells display atypical or epithelioid features. Accurate identification is essential for proper measurement of Breslow depth in melanomas arising in association with nevi and for margin assessment, both of which are critical for patient prognosis. The dual multiplex immunohistochemical stain utilizing Melan-A (red chromogen) and Ki67 (brown chromogen) is a valuable tool for assessing the proliferative index of melanocytic populations, with melanoma cells typically showing a higher Ki67 index than nevus cells.
METHODSWe identified 10 cases with invasive melanoma and associated nevus present on the same scanned histologic section for which the signing pathologist had ordered this dual multiplex immunohistochemical study. We annotated areas of melanoma versus nevus, then quantified the staining intensities.
RESULTSMelanoma cells often demonstrate more intense Melan-A red chromogen labeling than adjacent nevus cells (p = 0.008; Wilcoxon signed rank test).
CONCLUSIONThis differential labeling provides a helpful visual distinction between melanoma and nevus cells within the same histologic section, enhancing diagnostic confidence beyond the difference in Ki67 proliferation index.
Abstract from PubMed
PMID 42530379 · DOI 10.1111/cup.70170